The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study ID
- NCT00001054
- Phase
- PHASE1
- Status
- Withdrawn
Conditions
- Chickenpox
- HIV Infections
- Herpes Simplex
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 12 Years
- Healthy Volunteers
- Not accepted
Interventions
- Valacyclovir hydrochloride — DRUG
Study Details
To obtain tolerance, safety, and pharmacokinetic data for oral valacyclovir hydrochloride ( 256U87 ) in HIV-1 infected children with herpes simplex virus infections ( cold sores ) and/or varicella / zoster virus infections ( chicken pox / shingles ). Varicella and zoster are common problems in HIV-infected children. It is believed that chronic oral therapy with acyclovir may result in subtherapeutic concentrations of acyclovir, resulting in resistance to that drug. Valacyclovir hydrochloride, which converts to acyclovir in the body, increases acyclovir bioavailability by 3-5 fold.
Key Dates
- Status verified
- Oct 2021
- Completion
- Jan 31, 2001
Study Design
- Enrollment
- 0 participants (actual)
- Primary purpose
- TREATMENT
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.Recruiting · Syneos Health · Wilmington, North Carolina
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- Skeletal Muscle Energetics and Fatiguability in Older IndividualsRecruiting · Johns Hopkins University · Baltimore, Maryland